Tacrolimus-Induced Diabetic Ketoacidosis and Effect of Switching to Everolimus: A Case Report

Tugcu M., Kasapoglu U., Boynuegri B., Can O., Gokce A. M., Ruhi C., ...More

TRANSPLANTATION PROCEEDINGS, vol.47, no.5, pp.1528-1530, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 47 Issue: 5
  • Publication Date: 2015
  • Doi Number: 10.1016/j.transproceed.2015.04.075
  • Journal Name: TRANSPLANTATION PROCEEDINGS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1528-1530
  • Acibadem Mehmet Ali Aydinlar University Affiliated: No

Abstract

Background. New-onset diabetes after transplantation (NODAT) is a common metabolic complication. Most conventional immunosuppressive medications, especially steroids and tacrolimus, are responsible for its development. NODAT may rarely be associated with severe, life-threating complications in kidney transplantation recipients.